{"id":"methadone-treatment-as-usual","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Constipation"},{"rate":"5-10%","effect":"Sedation"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Abdominal pain"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Insomnia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Methadone's mechanism of action involves binding to mu-opioid receptors, which are responsible for the euphoric effects of opioids. By activating these receptors, methadone helps to reduce the severity of withdrawal symptoms and cravings, making it easier for individuals to manage their opioid use disorder. Additionally, methadone's long half-life allows for once-daily dosing, which can improve adherence and reduce the risk of overdose.","oneSentence":"Methadone is a mu-opioid receptor agonist that works by activating opioid receptors in the brain, reducing withdrawal symptoms and cravings in individuals with opioid use disorder.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:21:01.183Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of opioid use disorder"}]},"trialDetails":[{"nctId":"NCT06338280","phase":"PHASE2","title":"Remotely Observed Methadone Evaluation II","status":"RECRUITING","sponsor":"Sonara Health","startDate":"2024-12-24","conditions":"Opioid Use Disorder","enrollment":100},{"nctId":"NCT05459402","phase":"PHASE2, PHASE3","title":"Divided or Single Exposure (DOSE) Study","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2023-02-21","conditions":"Opioid Use Disorder, Chronic Pain, Methadone","enrollment":150},{"nctId":"NCT07296770","phase":"PHASE3","title":"An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-05-01","conditions":"Postsurgical Pain Management, Postsurgical Pain, Chronic, Opioid Use After Surgery","enrollment":126},{"nctId":"NCT05766631","phase":"PHASE3","title":"Treating Polysubstance Use Using a Novel Digital Technology","status":"RECRUITING","sponsor":"Friends Research Institute, Inc.","startDate":"2023-07-26","conditions":"Opioid Use, Opioid Use Disorder, Cocaine Use","enrollment":240},{"nctId":"NCT04345718","phase":"PHASE2, PHASE3","title":"EXHIT ENTRE Comparative Effectiveness Trial","status":"COMPLETED","sponsor":"Gavin Bart","startDate":"2021-08-09","conditions":"Substance Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe","enrollment":344},{"nctId":"NCT07262190","phase":"NA","title":"NavSTAR Implementation Effectiveness Trial Across a Health System","status":"RECRUITING","sponsor":"Friends Research Institute, Inc.","startDate":"2025-10-27","conditions":"Opioid Use Disorder","enrollment":720},{"nctId":"NCT05299515","phase":"NA","title":"Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence","status":"COMPLETED","sponsor":"University of Maryland, College Park","startDate":"2022-04-05","conditions":"Substance-Related Disorders, Opioid Medication Assisted Treatment, Opioid Use Disorder","enrollment":200},{"nctId":"NCT06877858","phase":"PHASE1","title":"MethaLoad Dose-Finding Study","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-09-25","conditions":"Opioid Use Disorder (OUD)","enrollment":24},{"nctId":"NCT07214389","phase":"NA","title":"PRoducing Outcome Measures for OTP Quality Improvement","status":"NOT_YET_RECRUITING","sponsor":"RTI International","startDate":"2025-10-03","conditions":"Opioid Use Disorder","enrollment":4500},{"nctId":"NCT05973838","phase":"NA","title":"Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention","status":"RECRUITING","sponsor":"University of Maryland, College Park","startDate":"2023-06-15","conditions":"Polysubstance Addiction, Opioid Medication Assisted Treatment, Treatment Adherence","enrollment":180},{"nctId":"NCT06032559","phase":"PHASE3","title":"Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2023-09-04","conditions":"Opioid Use, Pain","enrollment":450},{"nctId":"NCT05204576","phase":"NA","title":"Computer Based Treatment for Cognitive Behavioral Therapy and Cooperative Pain Education and Self-Management","status":"COMPLETED","sponsor":"Yale University","startDate":"2022-07-15","conditions":"Opioid Use Disorder, Chronic Pain","enrollment":160},{"nctId":"NCT05189223","phase":"NA","title":"A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-09-01","conditions":"Dependence, Opioid","enrollment":50},{"nctId":"NCT06021431","phase":"NA","title":"Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT","status":"ACTIVE_NOT_RECRUITING","sponsor":"BehaVR LLC","startDate":"2023-09-07","conditions":"Opioid Use Disorder","enrollment":128},{"nctId":"NCT05534815","phase":"NA","title":"Long-Term Treatment of Opioid Use Disorder","status":"RECRUITING","sponsor":"Northern Michigan University","startDate":"2023-03-01","conditions":"Drug Addiction, Employment","enrollment":225},{"nctId":"NCT06288711","phase":"NA","title":"Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD","status":"RECRUITING","sponsor":"University of Vermont","startDate":"2024-06-03","conditions":"Opioid Use Disorder, Posttraumatic Stress Disorder","enrollment":135},{"nctId":"NCT04491968","phase":"NA","title":"Mindfulness Oriented Recovery Enhancement for Chronic Pain and Opioid Relapse","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-08-13","conditions":"Opioid Use, Chronic Pain","enrollment":154},{"nctId":"NCT01857245","phase":"NA","title":"Intensive Models of HCV Care for Injection Drug Users","status":"COMPLETED","sponsor":"Prisma Health-Upstate","startDate":"2013-10-01","conditions":"Hepatitis C, Medication Adherence","enrollment":150},{"nctId":"NCT04104022","phase":"NA","title":"Prolonged Exposure Therapy for PTSD and Opioid Use Disorder","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2021-04-06","conditions":"Post Traumatic Stress Disorder, Opioid-use Disorder","enrollment":52},{"nctId":"NCT03212794","phase":"NA","title":"Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2019-02-11","conditions":"Opioid-use Disorder","enrollment":29},{"nctId":"NCT04798534","phase":"NA","title":"Intervention to Facilitate MMT/HIV Service Decentralization in Vietnam","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2020-08-28","conditions":"Opioid-use Disorder","enrollment":120},{"nctId":"NCT05251376","phase":"PHASE1","title":"Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy","status":"WITHDRAWN","sponsor":"Lyndra Inc.","startDate":"2022-02-28","conditions":"Opioid Use Disorder, Moderate","enrollment":""},{"nctId":"NCT04308694","phase":"EARLY_PHASE1","title":"Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment","status":"COMPLETED","sponsor":"Friends Research Institute, Inc.","startDate":"2020-08-06","conditions":"Opioid-use Disorder","enrollment":20},{"nctId":"NCT03894501","phase":"NA","title":"Pilot of Mindfulness Oriented Recovery Enhancement in MethadoneTreatment","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2019-01-31","conditions":"Opioid Use, Chronic Pain","enrollment":30},{"nctId":"NCT03127358","phase":"NA","title":"Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2017-11-14","conditions":"Hepatitis C, Medication Adherence","enrollment":11},{"nctId":"NCT01999946","phase":"PHASE4","title":"Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2014-06-27","conditions":"Heroin Dependence, Opioid-Related Disorders","enrollment":217},{"nctId":"NCT01378858","phase":"NA","title":"Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2011-07","conditions":"Tobacco Use Disorder, Medication Adherence","enrollment":100},{"nctId":"NCT03254043","phase":"NA","title":"Evaluating a Novel Medication Device for Methadone Dosing","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-01-31","conditions":"Opioid-use Disorder","enrollment":26},{"nctId":"NCT02334215","phase":"NA","title":"A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail","status":"COMPLETED","sponsor":"Friends Research Institute, Inc.","startDate":"2014-12-15","conditions":"Opioid Use Disorder","enrollment":225},{"nctId":"NCT02941809","phase":"NA","title":"Harnessing Placebo Effects in Methadone Treatment","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2017-12-05","conditions":"Opioid-use Disorder, Opioid-Related Disorders","enrollment":133},{"nctId":"NCT01315184","phase":"PHASE2","title":"Study of Computer-Based Treatment for Drug Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2010-07","conditions":"Opioid-Related Disorders, Heroin Dependence","enrollment":36},{"nctId":"NCT01389180","phase":"PHASE3","title":"Behavioral Drug and HIV Risk Reduction Counseling With MMT in China","status":"COMPLETED","sponsor":"Yale University","startDate":"2010-12","conditions":"Opiate Dependence","enrollment":300},{"nctId":"NCT04133974","phase":"NA","title":"Methadone Induced Memory Retrieval-extinction Procedure in Heroin Addicts","status":"COMPLETED","sponsor":"National Institute on Drug Dependence, China","startDate":"2015-11-20","conditions":"Heroin Dependence","enrollment":87},{"nctId":"NCT00386243","phase":"NA","title":"Evaluation of Stepped Care for Chronic Pain in Iraq/Afghanistan Veterans (ESCAPE)","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2007-12","conditions":"Low Back Pain, Pain, Pain, Intractable","enrollment":242},{"nctId":"NCT00809835","phase":"PHASE2","title":"Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-12","conditions":"Cocaine Dependence","enrollment":120},{"nctId":"NCT03721380","phase":"NA","title":"Efficacy of Drug and Risk Behavior Counseling Intervention Among Injecting Drug Users at Opioid Substitution Treatment","status":"COMPLETED","sponsor":"National Taiwan University","startDate":"2012-05-14","conditions":"Substance Use Disorders","enrollment":118},{"nctId":"NCT00218634","phase":"NA","title":"Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2005-02","conditions":"Adherence, Depression, Heroin Dependence","enrollment":89},{"nctId":"NCT01442493","phase":"NA","title":"Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment","status":"COMPLETED","sponsor":"Friends Research Institute, Inc.","startDate":"2011-09","conditions":"Opiate Dependence","enrollment":300},{"nctId":"NCT01416584","phase":"NA","title":"A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2008-10","conditions":"Opiate Dependence","enrollment":98},{"nctId":"NCT02124980","phase":"NA","title":"Automated Recovery Line for Medication Assisted Treatment","status":"COMPLETED","sponsor":"Yale University","startDate":"2015-11","conditions":"Drug Dependence, Substance Use Disorders","enrollment":60},{"nctId":"NCT00218556","phase":"NA","title":"Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2004-01","conditions":"Depressive Disorder, Major, Hepatitis C","enrollment":42},{"nctId":"NCT01360463","phase":"PHASE2","title":"Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta, Indonesia","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2009-05","conditions":"HIV Risk Behaviors, Heroin Injection, Retention in Methadone Treatment","enrollment":276},{"nctId":"NCT00844272","phase":"PHASE4","title":"Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2005-05","conditions":"Intravenous Drug Abuse, Chronic Hepatitis C","enrollment":189},{"nctId":"NCT00712036","phase":"NA","title":"Entry Into Comprehensive Methadone Treatment Via Interim Maintenance","status":"COMPLETED","sponsor":"Friends Research Institute, Inc.","startDate":"2008-06","conditions":"Opiate Dependence","enrollment":230},{"nctId":"NCT01723527","phase":"PHASE1","title":"Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-12","conditions":"Cocaine-Related Disorders, HIV, Heroin Dependence","enrollment":1},{"nctId":"NCT00668265","phase":"PHASE4","title":"Anxiety in Recovering Opiate Dependence","status":"TERMINATED","sponsor":"Beth Israel Medical Center","startDate":"2008-01","conditions":"Generalized Anxiety Disorder, Comorbid Opiate Dependence in Remission, Status Post Methadone-Maintenance Treatment","enrollment":14},{"nctId":"NCT00958763","phase":"PHASE2","title":"Alcohol Use Reduction in Methadone Individuals With Hepatitis C Virus(HCV)","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2006-03","conditions":"Hepatitis C","enrollment":219}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":75,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Methadone Treatment-As-Usual","genericName":"Methadone Treatment-As-Usual","companyName":"Friends Research Institute, Inc.","companyId":"friends-research-institute-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methadone is a mu-opioid receptor agonist that works by activating opioid receptors in the brain, reducing withdrawal symptoms and cravings in individuals with opioid use disorder. Used for Treatment of opioid use disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}